Literature DB >> 28161600

Equine viral arteritis in breeding and sport horses in central Spain.

Fatima Cruz-Lopez1, Richard Newton2, Ana Sanchez-Rodriguez3, Joanne Ireland2, Lapo Mughini-Gras4, Miguel A Moreno5, Paloma Fores3.   

Abstract

Equine viral arteritis (EVA) may have a high economic impact on breeding stud farms due to the occurrence of EVA-associated abortion outbreaks and the ability of the virus to persist in carrier stallions. While the consequences of EVA in premises with sport horses are usually less severe, the first confirmed outbreak of EVA in Spain occurred in a riding club in Barcelona, but no data on the seroprevalence of EVA in sport horses have been reported in Spain. Given the importance of both Spanish Purebred (SP) breeding horses and sport horses for Spain's equine industry, the aim of this study was to determine and compare the seroprevalence of EVA in these two horse populations in central Spain. Serum samples from 155 SP breeding horses residing in 16 stud farms and 105 sport horses of different breeds housed in 12 riding clubs, collected between September 2011 and November 2013, were tested using a commercial EVA antibody ELISA test with a 100% sensitivity, and confirmed by seroneutralisation (SN) test. EVA seroprevalence in SP breeding horses was higher 21.1% (95% CI 15.3-26.8%) than that in sport horses (6.7%, 95% CI 1.89-11.45%). However, the primary use (breeding vs. sport) was not significantly associated with seropositivity to Equine Arteritis Virus (EAV), suggesting that different management factors do not affect EVA circulation in these two horse populations.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Equine viral arteritis (EVA); Madrid; Seroprevalence; Spain; Spanish Purebred; Sport horse

Mesh:

Year:  2017        PMID: 28161600     DOI: 10.1016/j.rvsc.2017.01.022

Source DB:  PubMed          Journal:  Res Vet Sci        ISSN: 0034-5288            Impact factor:   2.534


  2 in total

1.  COVID-19: A Personalized Cardiometabolic Approach for Reducing Complications and Costs. The Role of Aging Beyond Topics.

Authors:  J Saban-Ruiz; D Ly-Pen
Journal:  J Nutr Health Aging       Date:  2020-05-12       Impact factor: 4.075

2.  COVID-19: A Personalized Cardiometabolic Approach for Reducing Complications and Costs. The Role of Aging beyond Topics.

Authors:  J Saban-Ruiz; D Ly-Pen
Journal:  J Nutr Health Aging       Date:  2020       Impact factor: 4.075

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.